Allergan (AGN), Nektar (NKTR) Shares Lower After Hours as Traders Wonder Where's the MAP (MAPP) News...

Investors are still anxiously waiting for FDA news on MAP Pharma's (Nasdaq: MAPP) Levadex. As the stock was halted just ahead of 2pm ET, traders are using shares of partners Allergan (NYSE: AGN) and Nektar Therapeutics (Nasdaq: NKTR) as a way to play MAP. After closing at $7.87 this afternoon, Nektar shares are down about 3 percent to $7.62 after hours. Shares of Allergan, meanwhile, are down about 0.3 percent to $94.50.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
• Anthropic hires Google chip veteran as it pushed into hardware - Bloomberg
• FTC files amicus brief challenging Amgen's Enbrel patent acquisition